Related references
Note: Only part of the references are listed.Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsy
Soraya Mehrabi et al.
METABOLIC BRAIN DISEASE (2018)
Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes
Fei-Juan Kong et al.
NEUROPHARMACOLOGY (2018)
A reappraisal on metformin
Tugba Adak et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease
Gentzane Sanchez-Elexpuru et al.
NEUROREPORT (2017)
Metformin protects the brain against ischemia/reperfusion injury through PI3K/Akt1/JNK3 signaling pathways in rats
Xu-Hua Ge et al.
PHYSIOLOGY & BEHAVIOR (2017)
Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users
Fedra Luciano-Mateo et al.
NUTRIENTS (2017)
Liraglutide activates autophagy via GLP-1R to improve functional recovery after spinal cord injury
Jian Chen et al.
ONCOTARGET (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Chronic metformin treatment facilitates seizure termination
Yong Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects
Caterina Palleria et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Which insights have we gained from the kindling and post-status epilepticus models?
Jan A. Gorter et al.
JOURNAL OF NEUROSCIENCE METHODS (2016)
Metformin Reduces Lipogenesis Markers in Obese Mice Fed a Low-Carbohydrate and High-Fat Diet
Karla Nayara de Oliveira Santana et al.
LIPIDS (2016)
The mTOR signalling cascade: paving new roads to cure neurological disease
Peter B. Crino
NATURE REVIEWS NEUROLOGY (2016)
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis
Rita Citraro et al.
PHARMACOLOGICAL RESEARCH (2016)
Differential metformin dose-dependent effects on cognition in rats: role of Akt
Dalia K. Mostafa et al.
PSYCHOPHARMACOLOGY (2016)
TORC2 Structure and Function
Christl Gaubitz et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
TOR Complexes and the Maintenance of Cellular Homeostasis
Sandra Eltschinger et al.
TRENDS IN CELL BIOLOGY (2016)
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial
S. Vigili de Kreutzenberg et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2015)
Caloric restriction protects against electrical kindling of the amygdala by inhibiting the mTOR signaling pathway
Bryan V. Phillips-Farfan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Sampling Blood from the Lateral Tail Vein of the Rat
Graham Lee et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
mTOR and autophagy in normal brain aging and caloric restriction ameliorating age-related cognition deficits
Fengying Yang et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice
Ran-ran Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
Single Rapamycin Administration Induces Prolonged Downward Shift in Defended Body Weight in Rats
Mark Hebert et al.
PLOS ONE (2014)
Effects of metformin on weight loss: potential mechanisms
Steven K. Malin et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2014)
Strategies for the management of adverse events associated with mTOR inhibitors
Bruce Kaplan et al.
TRANSPLANTATION REVIEWS (2014)
Animal models of epilepsy: use and limitations
Ludmyla Kandratavicius et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Central administration of metformin into the third ventricle of C57BL/6 mice decreases meal size and number and activates hypothalamic S6 kinase
Hyun-Ju Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway
Sharon S. McDaniel et al.
EPILEPSIA (2011)
Caloric Restriction Alters Seizure Disposition and Behavioral Profiles in Seizure-Prone (Fast) Versus Seizure-Resistant (Slow) Rats
Ataa Azarbar et al.
BEHAVIORAL NEUROSCIENCE (2010)
Metformin Reduces Body Weight Gain and Improves Glucose Intolerance in High-Fat Diet-Fed C57BL/6J Mice
Yukari Matsui et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Toxicity and toxicokinetics of metformin in rats
Michael P. Quaile et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
R. J. Shaw
ACTA PHYSIOLOGICA (2009)
Ketogenic Diets: Evidence for Short- and Long-term Efficacy
Eric H. Kossoff et al.
NEUROTHERAPEUTICS (2009)
TOR complex 2: a signaling pathway of its own
Nadine Cybulski et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Effect of mTOR inhibitor on body weight:: from an experimental rat model to human transplant patients
Jordi Rovira et al.
TRANSPLANT INTERNATIONAL (2008)
Metformin therapy in a transgenic mouse model of Huntington's disease
Thong C. Ma et al.
NEUROSCIENCE LETTERS (2007)
Neuroprotective and disease-modifying effects of the ketogenic diet
Maciej Gasior et al.
BEHAVIOURAL PHARMACOLOGY (2006)
Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo
KJ Bough et al.
EPILEPSIA (2003)
Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose
AE Greene et al.
EPILEPSIA (2001)
Share Paper
